| identifier: | 1841630 |
| description: |
epitope description:alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
host organism:Oryctolagus cuniculus New Zealand White
|
| aggregation: |
instance of dataset
|
| availability: |
available
|
| primaryPublications: |
16516981 |
| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1001345 |
| landingPage: |
http://www.iedb.org/assay/1841630 |
| type: |
Literature
|
| publicationVenue: |
J Neuroimmunol
|
| dates: |
2006
|
| study type: | b cell assays |
| subject species: | Bos taurus |
| fullName: |
Christina M Caporale
Margherita Capasso
Mirella Luciani
Vincenza Prencipe
Beatrice Creati
Paola Gandolfi
Maria V De Angelis
Antonio Di Muzio
Vincenzo Caporale
Antonino Uncini
|
| method: |
ELISA
|
| name: |
Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
|
| description: |
The ganglioside was obtained commercially. It is purified from bovine brain.
Anti-GD1a IgM titers could already be detected in both groups (with or without KLH co-immunization) 2 weeks after the first immunization and reached a plateau after 2-3 doses.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |